Jan 09, 2008 7:30am EST Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
Dec 13, 2007 7:30am EST Rigel's R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
Dec 06, 2007 7:30am EST Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
Dec 05, 2007 7:30am EST Rigel Announces Presentations at the 2007 American Society of Hematology (ASH) Meeting
Nov 21, 2007 2:40pm EST Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP
Nov 14, 2007 7:30am EST Merck Serono Exercises Option to Rigel's R763/AS703569 and Aurora Kinase Inhibitors in the Japanese Territory
Nov 09, 2007 11:40am EST Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
Oct 30, 2007 7:30am EDT Rigel Announces Presentations at Upcoming Investor and Partnering Conferences
